PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-30.62%
Both yoy net incomes decline, with MRVL at -82.75%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
0.08%
Some D&A expansion while MRVL is negative at -1.25%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
36.67%
Some yoy growth while MRVL is negative at -100.57%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
5.96%
SBC growth while MRVL is negative at -12.49%. John Neff would see competitor possibly controlling share issuance more tightly.
-115.82%
Both reduce yoy usage, with MRVL at -547.18%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-79.87%
AR is negative yoy while MRVL is 5.53%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
159.91%
Some inventory rise while MRVL is negative at -164.91%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-82.45%
Negative yoy AP while MRVL is 128.16%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-110.75%
Both reduce yoy usage, with MRVL at -258.88%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-19.77%
Negative yoy while MRVL is 153.91%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-44.44%
Both yoy CFO lines are negative, with MRVL at -62.12%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
3.37%
Some CapEx rise while MRVL is negative at -29.74%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-72.21%
Both yoy lines negative, with MRVL at -14.21%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
136.96%
We have some liquidation growth while MRVL is negative at -0.29%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
99.65%
Growth well above MRVL's 72.72%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
26.14%
We have mild expansions while MRVL is negative at -48.56%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-32.10%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-100.00%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-1372.22%
We cut yoy buybacks while MRVL is 4.32%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.